News
The original poster (OP), user My_Alchemy22, shared their story on Reddit, explaining that their aunt is someone who ...
A single infusion of zimislecel, an investigational stem cell-based therapy, restored physiologic islet function and ...
Eli Lilly plans to acquire Verve for up to $1.3 billion. Shares of Verve Therapeutics (NASDAQ: VERV) were skyrocketing 75.7% ...
When a teacher was told therapy animals were visiting her school, she naturally assumed dogs would be involved. Instead, she ...
The publisher launched its fifth sponsored tool, a Room Planner sponsored by Discover, on Thursday. - Apartment Therapy, ...
In this week’s edition of The Prototype, we look at a big space stock IPO, Korea’s plan to dominate the world of robots, ...
Shares of Insmed jumped Tuesday after the biopharmaceutical firm reported positive results from a Phase 2 trial for its ...
U.S. stock futures point higher, Victoria's Secret shares rise on a report that an activist investor is building a stake in ...
In such a scenario, choosing one stock over another can be challenging ... The industry has declined 4.1% in the said period. Image Source: Zacks Investment Research From a valuation standpoint ...
Eli Lilly (NYSE: LLY) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following recent clinical wins, the company may even be taking the lead ahead of its ...
15d
Zacks Investment Research on MSNTPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer TherapyTempest Therapeutics TPST announced that the European Medicines Agency (EMA) has granted an orphan drug designation (ODD) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results